Ducci F and Goldman D: The genetic basis of addictive disorders. Psychiatr Clin North Am. 35:495–519. 2012.PubMed/NCBI View Article : Google Scholar

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 5th edition. American Psychiatric Association, Washington, DC, 2013.

World Health Organization: ICD-10: International Statistical Classification of Diseases and Related Health Problems: 10th revision, 2nd edition. World Health Organization, 2004. Available from: https://apps.who.int/iris/handle/10665/42980.

Rumpf HJ, Achab S, Billieux J, Bowden-Jones H, Carragher N, Demetrovics Z, Higuchi S, King DL, Mann K, Potenza M, et al: Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective. J Behav Addict. 7:556–561. 2018.PubMed/NCBI View Article : Google Scholar

International Statistical Classification of Diseases and Related Health Problems (11th edition) ICD-11, World Health Organization, 2020.

Trifu S, Mihailescu R, Stegarescu S and Ion I: Evolutional Perspective Over Some Key-Aspects in Psychiatry. Theoretical and Applied in Psychology (SICAP23): Psychology and Ongoing Development. Editografica, Bologna, pp179, 2016.

Winger G, Woods JH, Galuska CM and Wade-Galuska T: Behavioral perspectives on the neuroscience of drug addiction. J Exp Anal Behav. 84:667–681. 2005.PubMed/NCBI View Article : Google Scholar

Koob GF and Volkow ND: Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry. 3:760–773. 2016.PubMed/NCBI View Article : Google Scholar

Jacqueline MV: Genetics of Addiction: Future Focus on Gene x environment interaction? J Stud Alcohol Drugs. 77:684–687. 2016.PubMed/NCBI View Article : Google Scholar

Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, et al: Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet. 16:24–35. 2007.PubMed/NCBI View Article : Google Scholar

Dick DM, Viken R, Purcell S, Kaprio J, Pulkkinen L and Rose RJ: Parental monitoring moderates the importance of genetic and environmental influences on adolescent smoking. J Abnorm Psychol. 116:213–218. 2007.PubMed/NCBI View Article : Google Scholar

Hancock DB, Markunas CA, Bierut LJ and Johnson EO: Human genetics of addiction: New insights and future directions. Curr Psychiatry Rep. 20(8)2018.PubMed/NCBI View Article : Google Scholar

Trifu S, Tudor A and Rădulescu I: Aggressive behavior in psychiatric patients in relation to hormonal imbalance (Review). Exp Ther Med. 20:3483–3487. 2020.PubMed/NCBI View Article : Google Scholar

Gräff J and Mansuy IM: Epigenetic dysregulation in cognitive disorders. Eur J Neurosci. 30:1–8. 2009.PubMed/NCBI View Article : Google Scholar

Schmidt HD, McGinty JF, West AE and Sadri-Vakili G: Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med. 3(a012047)2013.PubMed/NCBI View Article : Google Scholar

Cadet JL, Brannock C, Jayanthi S and Krasnova IN: Transcriptional and epigenetic substrates of methamphetamine addiction and withdrawal: Evidence from a long-access self-administration model in the rat. Mol Neurobiol. 51:696–717. 2015.PubMed/NCBI View Article : Google Scholar

Cadet JL: Epigenetics of stress, addiction, and resilience: Therapeutic implications. Mol Neurobiol. 53:545–560. 2016.PubMed/NCBI View Article : Google Scholar

Covington HE III, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, Dietz DM, Lobo MK, Ghose S, Mouzon E, et al: A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron. 71:656–670. 2011.PubMed/NCBI View Article : Google Scholar

Walker CD: Maternal touch and feed as critical regulators of behavioral and stress responses in the offspring. Dev Psychobiol. 52:638–650. 2010.PubMed/NCBI View Article : Google Scholar

Mychasiuk R, Harker A, Ilnytskyy S and Gibb R: Paternal stress prior to conception alters DNA methylation and behaviour of developing rat offspring. Neuroscience. 241:100–105. 2013.PubMed/NCBI View Article : Google Scholar

Benton D and Young HA: A meta-analysis of the relationship between brain dopamine receptors and obesity: A matter of changes in behavior rather than food addiction? Int J Obes (Lond). 40 (Suppl 1):S12–S21. 2016.PubMed/NCBI View Article : Google Scholar

Standaert DG and Walsh RR: Pharmacology of dopaminergic neurotransmission. In: Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. Tashjian AH, Armstrong EJ and Golan DE (eds). Lippincott Williams & Wilkins, Philadelphia pp186-206, 2011.

Mishra A, Singh S and Shukla S: Physiological and functional basis of dopamine receptors and their role in neurogenesis: Possible implication for Parkinson's disease. J Exp Neurosci: May 31, 2018 (Epub ahead of print). doi: 10.1177/1179069518779829.

Gardner EL: Addiction and brain reward and antireward pathways. Adv Psychosom Med. 30:22–60. 2011.PubMed/NCBI View Article : Google Scholar

Zhornitsky S, Rizkallah É, Pampoulova T, Chiasson JP, Stip E, Rompré PP and Potvin S: Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. J Clin Psychopharmacol. 30:417–424. 2010.PubMed/NCBI View Article : Google Scholar

Frazer A and Hensler JG: Serotonin Involvement in Physiological Function and Behavior. In: Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Siegel GJ, Agranoff BW and Albers RW (eds). 6th edition. Lippincott-Raven, Philadelphia, 1999.

Palacios JM, Pazos A and Hoyer D: A short history of the 5-HT2C receptor: From the choroid plexus to depression, obesity and addiction treatment. Psychopharmacology (Berl). 234:1395–1418. 2017.PubMed/NCBI View Article : Google Scholar

Maria Alexandra Stanescu A, Totan A, Mircescu D, Diaconescu S, Gabriel Bratu O, Fekete L, László Fekete G, Boda D and Cristina Diaconu C: Assessment of suicidal behavior in dermatology (Review). Exp Ther Med. 20:73–77. 2020.PubMed/NCBI View Article : Google Scholar

Kirby LG, Zeeb FD and Winstanley CA: Contributions of serotonin in addiction vulnerability. Neuropharmacology. 61:421–432. 2011.PubMed/NCBI View Article : Google Scholar

Vogeler T, McClain C and Evoy KE: Combination bupropion SR and varenicline for smoking cessation: A systematic review. Am J Drug Alcohol Abuse. 42:129–139. 2016.PubMed/NCBI View Article : Google Scholar

Zagon IS and McLaughlin PJ: Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis. In: Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Zagon IS and McLaughlin PJ (eds). Codon Publications, Brisbane, AU, 2017.

Herman JP, Figueiredo HF, Mueller NK, Ostrander MM, Zhang R, Tauchi M, Choi DC, Furay AR, Evanson NK, Nelson EB, et al: Neurochemical Systems Regulating the Hypothalamo-Pituitary-Adrenocortical Axis. In: Handbook of Neurochemistry and Molecular Neurobiology. Lajtha A and Blaustein JD (eds). Springer, Boston, pp513-569, 2007.

Browning KN and Travagli RA: Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol. 4:1339–1368. 2014.PubMed/NCBI View Article : Google Scholar

Gilpin NW and Koob GF: Neurobiology of alcohol dependence: Focus on motivational mechanisms. Alcohol Res Health. 31:185–195. 2008.PubMed/NCBI

Aboujaoude E and Salame WO: Naltrexone: A Pan-Addiction treatment? CNS Drugs. 30:719–733. 2016.PubMed/NCBI View Article : Google Scholar

Mark GP, Shabani S, Dobbs LK and Hansen ST: Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav. 104:76–81. 2011.PubMed/NCBI View Article : Google Scholar

Sofuoglu M and Mooney M: Cholinergic functioning in stimulant addiction: Implications for medications development. CNS Drugs. 23:939–952. 2009.PubMed/NCBI View Article : Google Scholar

Williams MJ and Adinoff B: The role of acetylcholine in cocaine addiction. Neuropsychopharmacology. 33:1779–1797. 2008.PubMed/NCBI View Article : Google Scholar

Enoch MA: The role of GABA(A) receptors in the development of alcoholism. Pharmacol Biochem Behav. 90:95–104. 2008.PubMed/NCBI View Article : Google Scholar

Tyacke RJ, Lingford-Hughes A, Reed LJ and Nutt DJ: GABAB receptors in addiction and its treatment. Adv Pharmacol. 58:373–396. 2010.PubMed/NCBI View Article : Google Scholar

Minozzi S, Saulle R and Rösner S: Baclofen for alcohol use disorder. Cochrane Database Syst Rev. 11(CD012557)2018.PubMed/NCBI View Article : Google Scholar

Volkow ND and Morales M: The Brain on drugs: From reward to addiction. Cell. 162:712–725. 2015.PubMed/NCBI View Article : Google Scholar

Li CT, Yang KC and Lin WCL: Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: Evidence from clinical neuroimaging studies. Front Psychiatry. 9(767)2019.PubMed/NCBI View Article : Google Scholar

Schultz W: Neuronal reward and decision signals: From theories to data. Physiol Rev. 95:853–951. 2015.PubMed/NCBI View Article : Google Scholar

Cooper S, Robison AJ and Mazei-Robison MS: Reward circuitry in addiction. Neurotherapeutics. 14:687–697. 2017.PubMed/NCBI View Article : Google Scholar

Stott SRW and Ang SL: The Generation of midbrain dopaminergic neurons. In: Patterning and Cell Type Specification in the Developing CNS and PNS. Rubenstein JLR and Rakic P (eds). Academic Press, Cambridge, pp435-453, 2013.

Olds J and Milner P: Positive reinforcement produced by electrical stimulation of the septal area and other regions of rat brain. J Comp Physiol Psychol. 47:419–27. 1954.PubMed/NCBI View Article : Google Scholar

Goeders NE and Smith JE: Cortical dopaminergic involvement in cocaine reinforcement. Science. 221:773–775. 1983.PubMed/NCBI View Article : Google Scholar

Edenberg H and Foroud T: Genetics and alcoholism. Nat Rev Gastroenterol Hepatol. 10:487–494. 2013.PubMed/NCBI View Article : Google Scholar

Vetreno RP and Crews FT: Current hypotheses on the mechanisms of alcoholism. Handb Clin Neurol. 125:477–497. 2014.PubMed/NCBI View Article : Google Scholar

Sullivan EV and Pfefferbaum A: Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berl). 180:583–594. 2005.PubMed/NCBI View Article : Google Scholar

Sharp BM and Chen H: Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco. Eur J Neurosci. 50:2164–2179. 2019.PubMed/NCBI View Article : Google Scholar

Benowitz NL: Pharmacology of nicotine: Addiction, smoking-induced disease and therapeutics. Annu Rev Pharmacol Toxicol. 49:57–71. 2009.PubMed/NCBI View Article : Google Scholar

D'Souza MS and Markou A: Neuronal mechanisms underlying development of nicotine dependence: Implications for novel smoking-cessation treatments. Addict Sci Clin Pract. 6:4–16. 2011.PubMed/NCBI

Durazzo TC, Meyerhoff DJ and Nixon SJ: Chronic cigarette smoking: Implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 7:3760–3791. 2010.PubMed/NCBI View Article : Google Scholar

Nichols DE: Psychedelics. Pharmacol Rev. 68:264–355. 2016.PubMed/NCBI View Article : Google Scholar

López-Giménez JF and González-Maeso J: Hallucinogens and Serotonin 5-HT(2A) receptor-mediated signaling pathways. Curr Top Behav Neurosci. 36:45–73. 2018.PubMed/NCBI View Article : Google Scholar

Weir E: Inhalant use and addiction in Canada. CMAJ. 164(397)2001.PubMed/NCBI

Kumar S, Grover S, Kulhara P, Mattoo SK, Basu D, Biswas P and Shah R: Inhalant abuse: A clinic-based study. Indian J Psychiatry. 50:117–120. 2008.PubMed/NCBI View Article : Google Scholar

Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, Costello H, Ogunbiyi MO, Bossong MG and Freeman TP: The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharmacol Ther. 195:132–161. 2019.PubMed/NCBI View Article : Google Scholar

Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, et al: Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 378:1888–1897. 2018.PubMed/NCBI View Article : Google Scholar

McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, Taylor A and Wright S: Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial. Am J Psychiatry. 175:225–231. 2018.PubMed/NCBI View Article : Google Scholar

Wijayendran SB, O'Neill A and Bhattacharyya S: The effects of cannabis use on salience attribution: A systematic review. Acta Neuropsychiatr. 30:43–57. 2018.PubMed/NCBI View Article : Google Scholar

Colizzi M, McGuire P, Pertwee RG and Bhattacharyya S: Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence. Neurosci Biobehav Rev. 64:359–381. 2016.PubMed/NCBI View Article : Google Scholar

Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA and Innis RB: Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 17:642–649. 2017.PubMed/NCBI View Article : Google Scholar

Renard J, Vitalis T, Rame M, Krebs MO, Lenkei Z, Le Pen G and Jay TM: Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex. Eur Neuropsychopharmacol. 26:55–64. 2016.PubMed/NCBI View Article : Google Scholar

Saffroy R, Lafaye G, Desterke C, Ortiz-Tudela E, Amirouche A, Innominato P, Pham P, Benyamina A and Lemoine A: Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction. Chronobiol Int. 36:122–134. 2019.PubMed/NCBI View Article : Google Scholar

Gerra MC, Manfredini M, Cortese E, Antonioni MC, Leonardi C, Magnelli F, Somaini L, Jayanthi S, Cadet JL and Donnini C: Genetic and environmental risk factors for cannabis use: Preliminary results for the role of parental care perception. Subst Use Misuse. 54:670–680. 2019.PubMed/NCBI View Article : Google Scholar

Hodgson K, Coleman JR, Hagenaars SP, Purves KL, Glanville K, Choi SW, O'Reilly P and Breen G: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Lewis CM: Cannabis use, depression and self-harm: Phenotypic and genetic relationships. Addiction. 115:482–492. 2020.PubMed/NCBI View Article : Google Scholar

Montalvo-Ortiz JL, Zhou H, D'Andrea I, Maroteaux L, Lori A, Smith A, Ressler KJ, Nuñez YZ, Farrer LA, Zhao H, et al: Translational studies support a role for serotonin 2B receptor (HTR2B) gene in aggression-related cannabis response. Mol Psychiatry. 23:2277–2286. 2018.PubMed/NCBI View Article : Google Scholar

Pasman JA, Verweij KJ, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BM, Ong JS, et al: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nat Neurosci. 21:1161–1170. 2018.PubMed/NCBI View Article : Google Scholar

Petrovska J, Coynel D, Fastenrath M, Milnik A, Auschra B, Egli T, Gschwind L, Hartmann F, Loos E, Sifalakis K, et al: The NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals. J Psychiatr Res. 91:116–123. 2017.PubMed/NCBI View Article : Google Scholar

Trifu S, Vladuți A and Trifu AI: Genetic aspects in schizophrenia. Receptoral theories. Metabolic theories. Rom J Morphol Embryol. 61:25–32. 2020.PubMed/NCBI View Article : Google Scholar

Spahn V, Fischer O, Endres-Becker J, Schäfer M, Stein C and Zöllner C: Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner. Pain. 154:598–608. 2013.PubMed/NCBI View Article : Google Scholar

Le Merrer J, Becker JA, Befort K and Kieffer BL: Reward processing by the opioid system in the brain. Physiol Rev. 89:1379–412. 2009.PubMed/NCBI View Article : Google Scholar

Schramm-Sapyta NL, Walker QD, Caster JM, Levin ED and Kuhn CM: Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology (Berl). 206:1–21. 2009.PubMed/NCBI View Article : Google Scholar

Van'tVeer A, Yano JM, Carroll FI, Cohen BM and Carlezon WA Jr: Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic. Neuropsychopharmacology. 37:2809–2816. 2012.PubMed/NCBI View Article : Google Scholar

Wang S: Historical review: Opiate addiction and opioid receptors. Cell Transplant. 28:233–238. 2019.PubMed/NCBI View Article : Google Scholar

Wang SC, Chen YC, Lee CH and Cheng CM: Opioid addiction, genetic susceptibility and medical treatments: A review. Int J Mol Sci. 20(4294)2019.PubMed/NCBI View Article : Google Scholar

Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H and Farrer LA: Genome-wide association study of opioid dependence: Multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 76:66–74. 2014.PubMed/NCBI View Article : Google Scholar

Kreek MJ, Nielsen DA and LaForge KS: Genes associated with addiction: Alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 5:85–108. 2004.PubMed/NCBI View Article : Google Scholar

Brett J and Murnion B: Management of benzodiazepine misuse and dependence. Aust Prescr. 38:152–155. 2015.PubMed/NCBI View Article : Google Scholar

Blum K, Gold M, Modestino EJ, Baron D, Boyett B, Siwicki D, Lott L, Podesta A, Roy AK, Hauser M, et al: Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS^®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)? J Syst Integr Neurosci: May 3, 2018 (Epub ahead of print). doi: 10.15761/JSIN.1000196.

Blum K, Modestino EJ, Lewis MG, Baron D, Steinberg B, Thanos PK, Downs BW, Siwicki D, Lott L, Braverman E, et al: Pro-dopamine regulator (KB220) a fifty year sojourn to combat reward deficiency syndrome (RDS): Evidence based bibliography (Annotated). CPQ Neurol Psychol: Dec 4, 2018 (Epub ahead of print).

Konopka A, Mak M, Grzywacz A, Murawiec S and Samochowiec J: Genetic and psychosocial factors for benzodiazepine addiction. An analysis based on the results of the authors' own research conducted in a group of benzodiazepines addicted and non-addicted individuals. Postepy Hig Med Dosw (Online). 71:205–213. 2017.PubMed/NCBI View Article : Google Scholar

Gossop M, Griffiths P, Powis B and Strang J: Cocaine: Patterns of use, route of administration, and severity of dependence. Br J Psychiatry. 164:660–664. 1994.PubMed/NCBI View Article : Google Scholar

Coe MA, Jufer Phipps RA, Cone EJ and Walsh SL: Bioavailability and pharmacokinetics of oral cocaine in humans. J Anal Toxicol. 42:285–292. 2018.PubMed/NCBI View Article : Google Scholar

Olivares EL, Kendler KS, Neale MC and Gillespie NA: The genetic and environmental association between parental monitoring and risk of cannabis, stimulants, and cocaine initiation in a sample of male twins: Does parenting matter? Twin Res Hum Genet. 19:297–305. 2016.PubMed/NCBI View Article : Google Scholar

Jensen KP: A review of genome-wide association studies of stimulant and opioid use disorders. Mol Neuropsychiatry. 2:37–45. 2016.PubMed/NCBI View Article : Google Scholar

Le Q, Yan B, Yu X, Li Y, Song H, Zhu H, Hou W, Ma D, Wu F, Zhou Y and Ma L: Drug-seeking motivation level in male rats determines offspring susceptibility or resistance to cocaine-seeking behaviour. Nat Commun. 8(15527)2017.PubMed/NCBI View Article : Google Scholar

Sepanjnia K, Modabbernia A, Ashrafi M, Modabbernia MJ and Akhondzadeh S: Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial. Neuropsychopharmacology. 37:2093–2100. 2012.PubMed/NCBI View Article : Google Scholar

Chen X, Xue L, Hou S, Jin Z, Zhang T, Zheng F and Zhan CG: Long-acting cocaine hydrolase for addiction therapy. Proc Natl Acad Sci USA. 113:422–427. 2016.PubMed/NCBI View Article : Google Scholar

Yu S, Zhu L, Shen Q, Bai X and Di X: Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol. 2015(103969)2015.PubMed/NCBI View Article : Google Scholar

LaVoie MJ, Card JP and Hastings TG: Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol. 187:47–57. 2004.PubMed/NCBI View Article : Google Scholar

Cadet JL and Bisagno V: Glial-neuronal ensembles: Partners in drug addiction-associated synaptic plasticity. Front Pharmacol. 5(204)2014.PubMed/NCBI View Article : Google Scholar

Krasnova IN, Justinova Z and Cadet JL: Methamphetamine addiction: Involvement of CREB and neuroinflammatory signaling pathways. Psychopharmacology (Berl). 233:1945–1962. 2016.PubMed/NCBI View Article : Google Scholar

Olsen CM: Natural rewards, neuroplasticity, and non-drug addictions. Neuropharmacology. 61:1109–1122. 2011.PubMed/NCBI View Article : Google Scholar

Lobo DS, Souza RP, Tong RP, Casey DM, Hodgins DC, Smith GJ, Williams RJ, Schopflocher DP, Wood RT, el-Guebaly N and Kennedy JL: Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol. 85:33–7. 2010.PubMed/NCBI View Article : Google Scholar

Yau YH and Potenza MN: Gambling disorder and other behavioral addictions: Recognition and treatment. Harv Rev Psychiatry. 23:134–146. 2015.PubMed/NCBI View Article : Google Scholar

Moragas L, Granero R, Stinchfield R, Fernández-Aranda F, Fröberg F, Aymamí N, Gómez-Peña M, Fagundo AB, Islam MA, Del Pino-Gutiérrez A, et al: Comparative analysis of distinct phenotypes in gambling disorder based on gambling preferences. BMC Psychiatry. 15(86)2015.PubMed/NCBI View Article : Google Scholar

Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC and Shaffer HJ: DSM-IV pathological gambling in the National comorbidity survey replication. Psychol Med. 38:1351–60. 2008.PubMed/NCBI View Article : Google Scholar

Grant JE, Odlaug BL and Chamberlain SR: Neural and psychological underpinnings of gambling disorder: A review. Prog Neuropsychopharmacol Biol Psychiatry. 65:188–193. 2016.PubMed/NCBI View Article : Google Scholar

Wilson D, da Silva Lobo DS, Tavares H, Gentil V and Vallada H: Family-based association analysis of serotonin genes in pathological gambling disorder: Evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci. 49:550–553. 2013.PubMed/NCBI View Article : Google Scholar

Weinstein AM: Computer and video game addiction-a comparison between game users and non-game users. Am J Drug Alcohol Abuse. 36:268–276. 2010.PubMed/NCBI View Article : Google Scholar

Trifu S: Neuroendocrine insights into burnout syndrome. Acta Endocrinol (Buchar). 15:404–405. 2019.PubMed/NCBI View Article : Google Scholar

Ko CH, Liu GC, Hsiao S, Yen JY, Yang MJ, Lin WC, Yen CF and Chen CS: Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res. 43:739–747. 2009.PubMed/NCBI View Article : Google Scholar

Park J, Sung JY, Kim DK, Kong ID, Hughes TL and Kim N: Genetic association of human Corticotropin-releasing hormone receptor 1 (CRHR1) with Internet gaming addiction in Korean male adolescents. BMC Psychiatry. 18(396)2018.PubMed/NCBI View Article : Google Scholar

Franchina V, Vanden Abeele M, Van Rooij AJ, Lo Coco G and De Marez L: Fear of Missing out as a predictor of problematic social media use and phubbing behavior among Flemish adolescents. Int J Environ Res Public Health. 15(2319)2018.PubMed/NCBI View Article : Google Scholar

Trifu S and Gutt A: Interpretative process-from utilization of predominant to psychotic decompensation. Procedia Soc Behav Sci. 187:429–433. 2014.

Ostlund SB and Balleine BW: On habits and addiction: An associative analysis of compulsive drug seeking. Drug Discov Today Dis Models. 5:235–245. 2008.PubMed/NCBI View Article : Google Scholar

Powell BJ, McMillen JC, Proctor EK, Carpenter CR, Griffey RT, Bunger AC, Glass JE and York JL: A compilation of strategies for implementing clinical innovations in health and mental health. Med Care Res Rev. 69:123–157. 2012.PubMed/NCBI View Article : Google Scholar